• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Folkehelseinstituttet
  • Publikasjoner fra CRIStin FHI
  • View Item
  •   Home
  • Folkehelseinstituttet
  • Publikasjoner fra CRIStin FHI
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Inflammatory markers in late pregnancy in association with postpartum depression-A nested case-control study

Bränn, Emma; Papadopoulos, Fotios; Fransson, Emma; White, Richard; Edvinsson, Åsa; Hellgren, Charlotte; Kamali-Moghaddam, Masood; Boström, Adrian; Schiöth, Helgi B.; Sundström-Poromaa, Inger; Skalkidou, Alkistis
Peer reviewed, Journal article
Published version
Thumbnail
View/Open
Brann_2017_Inf.pdf (1.899Mb)
URI
http://hdl.handle.net/11250/2457928
Date
2017
Metadata
Show full item record
Collections
  • Artikler [6786]
  • Publikasjoner fra CRIStin FHI [9356]
Original version
Psychoneuroendocrinology. 2017, 79 146-159.   10.1016/j.psyneuen.2017.02.029
Abstract
Recent studies indicate that the immune system adaptation during pregnancy could play a significant role in the pathophysiology of perinatal depression. The aim of this study was to investigate if inflammation markers in a late pregnancy plasma sample can predict the presence of depressive symptoms at eight weeks postpartum. Blood samples from 291 pregnant women (median and IQR for days to delivery, 13 and 7-23 days respectively) comprising 63 individuals with postpartum depressive symptoms, as assessed by the Edinburgh postnatal depression scale (EPDS >= 12) and/or the Mini International Neuropsychiatric Interview (M.I.N.I.) and 228 controls were analyzed with an inflammation protein panel using multiplex proximity extension assay technology, comprising of 92 inflammation-associated markers. A summary inflammation variable was also calculated. Logistic regression, LASSO and Elastic net analyses were implemented. Forty markers were lower in late pregnancy among women with depressive symptoms postpartum. The difference remained statistically significant for STAM-BP (or otherwise AMSH), AXIN-1, ADA, ST1A1 and IL-10, after Bonferroni correction. The summary inflammation variable was ranked as the second best variable, following personal history of depression, in predicting depressive symptoms postpartum. The protein-level findings for STAM-BP and ST1A1 were validated in relation to methylation status of loci in the respective genes in a different population, using openly available data. This explorative approach revealed differences in late pregnancy levels of inflammation markers between women presenting with depressive symptoms postpartum and controls, previously not described in the literature. Despite the fact that the results do not support the use of a single inflammation marker in late pregnancy for assessing risk of postpartum depression, the use of STAM-BP or the novel notion of a summary inflammation variable developed in this work might be used in combination with other biological markers in the future. (C) 2017 The Authors. Published by Elsevier Ltd.
Journal
Psychoneuroendocrinology

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit